Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.
Nussenblatt RB, Thompson DJ, Li Z, Chan CC, Peterson JS, Robinson RR, Shames RS, Nagarajan S, Tang MT, Mailman M, Velez G, Roy C, Levy-Clarke GA, Suhler EB, Djalilian A, Sen HN, Al-Khatib S, Ursea R, Srivastava S, Bamji A, Mellow S, Sran P, Waldmann TA, Buggage RR. Nussenblatt RB, et al. J Autoimmun. 2003 Nov;21(3):283-93. doi: 10.1016/s0896-8411(03)00113-6. J Autoimmun. 2003. PMID: 14599854 Clinical Trial.
Retinal vasculitis.
Levy-Clarke GA, Nussenblatt R. Levy-Clarke GA, et al. Int Ophthalmol Clin. 2005 Spring;45(2):99-113. doi: 10.1097/01.iio.0000155905.95303.1d. Int Ophthalmol Clin. 2005. PMID: 15791161 Review. No abstract available.
Diagnosis and management of primary intraocular lymphoma.
Levy-Clarke GA, Chan CC, Nussenblatt RB. Levy-Clarke GA, et al. Hematol Oncol Clin North Am. 2005 Aug;19(4):739-49, viii. doi: 10.1016/j.hoc.2005.05.011. Hematol Oncol Clin North Am. 2005. PMID: 16083834 Review.
A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.
Buggage RR, Levy-Clarke G, Sen HN, Ursea R, Srivastava SK, Suhler EB, Altemare C, Velez G, Ragheb J, Chan CC, Nussenblatt RB, Bamji AT, Sran P, Waldmann T, Thompson DJ. Buggage RR, et al. Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):63-70. doi: 10.1080/09273940701299370. Ocul Immunol Inflamm. 2007. PMID: 17558830 Free PMC article. Clinical Trial.
74 results